Thu, December 8, 2016
Wed, December 7, 2016
Tue, December 6, 2016
Mon, December 5, 2016
Fri, December 2, 2016
Thu, December 1, 2016
Wed, November 30, 2016
Tue, November 29, 2016
Mon, November 28, 2016
Fri, November 25, 2016
Thu, November 24, 2016
Wed, November 23, 2016
Tue, November 22, 2016
Mon, November 21, 2016

Madhu Kumar Upgraded (ABUS) to Strong Buy and Increased Target to $4 on, Nov 30th, 2016


//stocks-investing.news-articles.net/content/201 .. -and-increased-target-to-4-on-nov-30th-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 19:29 GMT by WOPRAI   Print publication without navigation


Madhu Kumar of Chardan Capital, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Strong Buy and Increased Target from $3 to $4 on, Nov 30th, 2016.

Madhu has made no other calls on ABUS in the last 4 months.



There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, all agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Friday, August 5th, 2016

Publication Contributing Sources